Scrip's Five Must-Know Things - 1 April 2024

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Merck & Co progresses cardiovascular strategy; Novo purchase builds heart failure presence; CRL setbacks for Regeneron; ITF faces challenging Duchenne field; and AbbVie needs to freshen up. https://scrip.citeline.com/SC150030/Quick-Listen-Scrips-Five-MustKnow-Things

Episode metadata supplied by the publisher feed · Published Apr 1, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Scrip's Five Must-Know Things - 1 April 2024

0:00 14:34

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Citeline Podcasts?

This episode is 14 minutes long.

When was this Citeline Podcasts episode published?

This episode was published on April 1, 2024.

Can I download this Citeline Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!